glp 1 gerd My thoughts exclusively --> PPIs aren't working for many patients on GLP-1 therapies! glp 1 indigestion Full article:
Description
In the SURMOUNT-1 trial, tirzepatide produced dose-dependent weight reductions, with average losses approaching or exceeding ~20% at higher doses in adults with obesity who did not have diabetes, numbers that markedly exceed historical pharmacotherapy benchmarks

Not patches

What matters most though is what patients are experiencing are they able to reliably access their medication

Because when it comes to long-term success, timing mattersbut support matters more

* Consult with HCP on appropriate management of your GLP-1 medication
